InsiderTrades.com logo
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

KAI Insider Trading

Insider Ownership Percentage: 19.89%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Kairos Minerals Insider Trading History Chart

This chart shows the insider buying and selling history at Kairos Minerals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Kairos Minerals Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for KAI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

Kairos Minerals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/3/2023Mark CalderwoodInsiderIssued444,444A$0.02A$7,555.55
7/26/2023Klaus EckhofInsiderIssued7,625,312A$0.02A$114,379.68
8/9/2022Zane LewisInsiderIssued17,500,000A$0.03A$577,500.00
7/21/2022Phillip CoulsonInsiderBuy4,861,145A$0.02A$111,806.34
4/1/2022Zane LewisInsiderBuy5,000,000A$0.03A$150,000.00
3/25/2022Phillip CoulsonInsiderBuy5,849,604A$0.03A$163,788.91
12/22/2021Bruno SenequeInsiderIssued132,206A$0.03A$3,305.15
See Full Table
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Kairos Minerals (ASX:KAI)

0.39% of Kairos Minerals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Kairos Minerals logo
Kairos Minerals Limited, together with its subsidiaries, operates as a resource exploration company in Australia. The company explores for gold, lead, zinc, copper, cobalt, nickel, and lithium properties. Its flagship project is the 100% owned Pilbara Gold project, which includes the Mt York deposit located to the south of Port Hedland in the Pilbara region. The company was formerly known as Mining Projects Group Limited and changed its name to Kairos Minerals Limited in April 2016. Kairos Minerals Limited was incorporated in 1983 and is based in Daglish, Australia.
Read More on Kairos Minerals

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

2,262,860 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

8.00%

Beta

1.45

Who are the company insiders with the largest holdings of Kairos Minerals?

Kairos Minerals' top insider investors include:
  1. Bruno Seneque (Insider)
  2. Klaus Eckhof (Insider)
  3. Mark Calderwood (Insider)
  4. Phillip Coulson (Insider)
  5. Zane Lewis (Insider)
Learn More about top insider investors at Kairos Minerals.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.